These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21489361)

  • 1. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patients.
    Marcella S; Goodman G; Cumming S; Foley P; Morgan V
    Australas J Dermatol; 2011 May; 52(2):123-6. PubMed ID: 21605096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N; Benohanian A; Kowalski JW;
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.
    Kouris A; Armyra K; Stefanaki C; Christodoulou C; Karimali P; Kontochristopoulos G
    Pediatr Dermatol; 2015; 32(2):226-30. PubMed ID: 25557249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
    Doft MA; Kasten JL; Ascherman JA
    Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
    Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
    Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
    Maillard H; Briand N; Bara C; Celerier P
    Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
    Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.